Endovascular Repair of Abdominal Aortic Aneurysm with the Ancure Endograft: CT Follow-up of Perigraft Flow and Aneurysm Size at 6 Months

2000 ◽  
Vol 11 (4) ◽  
pp. 429-435 ◽  
Author(s):  
Thomas J. Franco ◽  
Albert B. Zajko ◽  
Michael P. Federle ◽  
Michel S. Makaroun
Vascular ◽  
2004 ◽  
Vol 12 (2) ◽  
pp. 106-113 ◽  
Author(s):  
William D. Jordan ◽  
Thomas C. Naslund ◽  
Mark A. Adelman ◽  
Gene Simoni ◽  
Douglas J. Wirthlin

Commercially available aortic stent grafts differ in construction and clinical advantage such that creating hybrid endografts by combining components from different manufacturers is sometimes useful. We describe a multicenter experience using hybrid endografts to treat patients with challenging anatomy. Hospital records and office charts were reviewed from four institutions. Hybrid endografts were defined as those with two types of covered stents in continuity to treat an abdominal aortic aneurysm (AAA). Indications for hybrid grafts were defined by type of endoleak and whether an endoleak was expected or unexpected as determined by the preoperative radiographic evaluation. Endpoints include intraoperative endoleaks, late endoleaks, change in aneurysm size, and rupture. Hybrid endografts were used to treat AAA (endovascular aneurysm repair [EVAR]) in 90 patients, representing 7.9% of the total multicenter experience. In 7 patients (7.8%), a hybrid graft construction as a secondary procedure successfully corrected a type 1 endoleak. In the remaining 83 patients (92.2%), hybrid grafts were created at the time of original EVAR to treat expected challenging anatomy or unexpected endoleaks. Hybrid endografts corrected 88 (97.8%) type 1 endoleaks, but 2 patients (2.2%) persisted with a proximal type 1 leak requiring conversion. During follow-up of 1 to 24 months, computed tomography and ultrasound surveillance, available for 73 patients (81.1%), detected one unresolved distal type 1 (1.1%) and seven type 2 (7.8%) endoleaks. Aneurysm size decreased at least 0.5 cm in 23 of 50 patients (46.0%) at 6 months and in 19 of 31 patients (61.3%) at 12 months. Aneurysm size increased at least 0.5 cm in 4 of 50 patients (8.0%) at 6 months and in 1 of 31 patients (3.2%) at 12 months. There were no ruptures. Hybrid endografts have favorable early and intermediate results in the treatment of AAA. Long-term follow-up will be needed to confirm the absence of significant adverse biomaterial interaction and the effect on AAA exclusion. We advocate the use of hybrid endografts as endovascular therapy for patients whose anatomy may be unsuitable for a single endograft type.


1999 ◽  
Vol 16 (6) ◽  
pp. 617-623
Author(s):  
ITZHAK KRONZON ◽  
MATHEW VARKEY ◽  
PAUL A. TUNICK ◽  
THOMAS RILES ◽  
ROBERT ROSEN

Author(s):  
Elena S. Di Martino ◽  
Michel S. Makaroun ◽  
David A. Vorp

The early benefits of an endovascular approach to abdominal aortic aneurysm (AAA) treatment has been reported by many authors [1,2]. One of the major advantages is that endovascular repair of AAA (EVAR) as opposed to traditional open surgery, is not a major abdominal surgery. EVAR has been shown to be associated with a death rate comparable to that of surgical repair [3]. In short term follow-up, EVAR is associated with fewer complications and a more rapid recovery [2]. On the contrary very limited data is available on long term follow-up of EVAR patients. Graft-related secondary interventions affect a consistent percentage of the treated cases. The EUROSTAR study [4] recently reported 13% of reintervention in 15.4 months. Our surgical unit reported 20.6% across 48 months in a recent review of 242 cases [3]. The frequence and type of reintervention, whose principal cause is endoleak or perigraft flow, requires careful consideration.


Radiology ◽  
2016 ◽  
Vol 279 (2) ◽  
pp. 410-419 ◽  
Author(s):  
Eli Salloum ◽  
Antony Bertrand-Grenier ◽  
Sophie Lerouge ◽  
Claude Kauffman ◽  
Hélène Héon ◽  
...  

2004 ◽  
Vol 18 (3) ◽  
pp. 271-279 ◽  
Author(s):  
Stéphane Elkouri ◽  
Jean M. Panneton ◽  
James C. Andrews ◽  
Bradley D. Lewis ◽  
Michael A. McKusick ◽  
...  

2008 ◽  
Vol 191 (3) ◽  
pp. 808-813 ◽  
Author(s):  
Cheng Hong ◽  
Jay P. Heiken ◽  
Gregorio A. Sicard ◽  
Thomas K. Pilgram ◽  
Kyongtae T. Bae

1997 ◽  
Vol 4 (1) ◽  
pp. 23-30 ◽  
Author(s):  
Martin Malina ◽  
Krasnodar Ivancev ◽  
Timothy A.M. Chuter ◽  
Mats Lindh ◽  
Toste Länne ◽  
...  

Purpose: To relate changing abdominal aortic aneurysm (AAA) morphology after endovascular grafting to the presence of leakage, collateral perfusion, and other factors. Methods: Thirty-five patients who underwent successful AAA endovascular grafting were evaluated. Self-expanding Z-stents and Dacron grafts were applied in bifurcated and aortomonoiliac systems. Postoperative diameter changes were calculated from repeated spiral computed tomographic scans, angiograms, and ultrasonic phase-locked echo-tracking scans during a median 6-month follow-up (interquartile range [IQR] 3 to 12). Results: At 12 months, the diameters of completely excluded aneurysms had decreased 6 mm (IQR 2 to 11; p = 0.006). The proximal graft-anchoring stents had dilated 2 mm (IQR 0.5 to 3.3; p = 0.01). The aortic diameters immediately below the renal arteries but above the stents had not changed. Endoleakage and collateral perfusion (n = 13) were each associated with preserved aneurysm size and a 12 times higher risk of aneurysm dilation. After the leakage or the collateral perfusion had been treated, the aneurysm size decreased. Aneurysms with extensive intraluminal thrombi presented a reduced risk of leakage or perfusion. Conclusions: The diameters of endovascularly excluded AAAs decrease, except in cases of leakage or perfusion. Careful follow-up of patients with aortic endografts is necessary.


1997 ◽  
Vol 4 (3) ◽  
pp. 279-283 ◽  
Author(s):  
Matthew P. Armon ◽  
S. Waquar Yusuf ◽  
Simon C. Whitaker ◽  
Roger H. S. Gregson ◽  
Peter W. Wenham ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document